MIC and time-kill study of antipneumococcal activities of RPR 106972 (a new oral streptogramin), RP 59500 (quinupristin-dalfopristin), pyostacine (RP 7293), penicillin G, cefotaxime, erythromycin, and clarithromycin against 10 penicillin-susceptible and -resistant pneumococci

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 9, 1996, Pages 2071-2074

  Pankuch, Glenn A ^a   Jacobs, Michael R ^b   Appelbaum, Peter C ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFOTAXIME; CLARITHROMYCIN; DALFOPRISTIN PLUS QUINUPRISTIN; ERYTHROMYCIN; PENICILLIN G; PRISTINAMYCIN; RPR 106972; STREPTOGRAMIN; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERICIDAL ACTIVITY; DRUG SENSITIVITY; MINIMUM INHIBITORY CONCENTRATION; PENICILLIN RESISTANCE; PRIORITY JOURNAL; STREPTOCOCCUS INFECTION;

EID: 0029795608     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.9.2071     Document Type: Article

References (23)

1. Appelbaum, P. C. 1992. Antimicrobial resistance in Streptococcus pneumoniae: an overview. Clin. Infect. Dis. 15:77-83.
2. Aumercier, M., S. Bouhallab, M.-L. Capmau, and F. Le Goffic. 1992. RP 59500: a proposed mechanism for its bactericidal activity. J. Antimicrob. Chemother. 30(Suppl. A):9-14.
3. Baquero, F., J. Martínez-Beltrán, and E. Loza. 1991. A review of antibiotic resistance patterns of Streptococcus pneumoniae in Europe. J. Antimicrob. Chemother. 28(Suppl. C):31-38.
4. Barrière, J. C., D. H. Bouanchaud, J. M. Paris, O. Rolin, N. V. Harris, and C. Smith. 1992. Antimicrobial activity against Staphylococcus aureus of semi-synthetic injectable streptogramins: RP 59500 and related compounds. J. Antimicrob. Chemother. 30(Suppl. A):1-8.
5. Barry, A. L., M. A. Pfaller, P. C. Fuchs, and R. R. Packer. 1994. In vitro activities of 12 orally administered antimicrobial agents against four species of bacterial respiratory pathogens from U.S. medical centers in 1992 and 1993. Antimicrob. Agents Chemother. 38:2419-2425.
6. Berthaud, N., A. M. Gouin, J. Rousseau, and J. F. Desnottes. 1993. RP 59500: killing kinetics against gram-positive cocci in an in vitro pharmacokinetic model, abstr. 1048, p. 311. In Program and abstracts of the 33rd Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
7. Geslin, P., A. Fremaux, G. Sissia, C. Spicq, and A. Aberrane. 1994. Epidémiologie de la résistance aux antibiotiques de Streptococcus pneumoniae en France. Réseau national de surveillance (1984-1993). Méd. Mal. Infect. 24:948-961.
8. Hofmann, J., M. S. Cetron, M. M. Farley, W. S. Baughman, R. R. Facklam, J. A. Elliott, K. A. Deaver, and R. F. Breiman. 1995. The prevalence of drug resistant Streptococcus pneumoniae in Atlanta. N. Engl. J. Med. 333:481-486.
9. Jacobs, M. R. 1992. Treatment and diagnosis of infections caused by drug-resistant Streptococcus pneumoniae. Clin. Infect. Dis. 15:119-127.
10. Johnson, C. C., L. Slavoski, M. Schwartz, P. May, A. Shur, P. G. Pitsakis, and M. E. Levinson. 1994. In vitro bactericidal activity of RP 59500 (Synercid) against antibiotic resistant strains of Streptococcus pneumoniae and Enterococcus spp., abstr. E9, p. 28. In Program and abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
11. Kam, K. M., K. Y. Luey, S. M. Fung, P. P. Yiu, T. J. Harden, and M. M. Cheung. 1995. Emergence of multiple-antibiotic-resistant Streptococcus pneumoniae in Hong Kong. Antimicrob. Agents Chemother. 39:2667-2670.
12. Klugman, K. P. 1990. Pneumococcal resistance to antibiotics. Clin. Microbiol. Rev. 3:171-196.
13. Liñares, J., T. Alonso, J. Ayats, F. Alcaide, F. Tubau, J. Hernandez, and R. Martín. 1991. In vitro activity of 7 macrolide antibiotics and 9 other antimicrobial agents against penicillin-resistant pneumococci, abstr. 191, p. 130. In Program and abstracts of the 31st Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology. Washington, D.C.
14. Mason, E. O. Jr., S. L. Kaplan, L. B. Lamberth, and J. Tillman. 1992. Increased rate of isolation of penicillin-resistant Streptococcus pneumoniae in a children's hospital and in vitro susceptibilities to antibiotics of potential therapeutic use. Antimicrob. Agents Chemother. 36:1703-1707.
15. McDougal, L. K., R. Facklam, M. Reeves, S. Hunter, J. M. Swenson, B. C. Hill, and F. C. Tenover. 1992. Analysis of multiply antimicrobial-resistant isolates of Streptococcus pneumoniae from the United States. Antimicrob. Agents Chemother. 36:2176-2184.
16. Muñoz, R., T. J. Coffey, M. Daniels, C. G. Dowson, G. Laible, J. Casal, R. Hakenbeck, M. Jacobs, J. M. Musser, B. G. Spratt, and A. Tomasz. 1991. Intercontinental spread of multiresistant clone of serotype 23F Streptococcus pneumoniae. J. Infect. Dis. 164:302-306.
17. National Committee for Clinical Laboratory Standards. 1993. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 3rd ed. Approved standard M7-A3. National Committee for Clinical Laboratory Standards, Villanova. Pa.
18. Nelson, C. T., E. O. Mason, Jr., and S. L. Kaplan. 1994. Activity of oral antibiotics in middle ear and sinus infections caused by penicillin-resistant Streptococcus pneumoniae: implications for treatment. Pediatr. Infect. Dis. J. 13:585-589.
19. Pankuch, G. A., M. R. Jacobs, and P. C. Appelbaum. 1994 Study of comparative antipneumococcal activities of penicillin G, RP 59500, erythromycin, sparfloxacin, ciprofloxacin, and vancomycin by using time-kill methodology. Antimicrob. Agents Chemother. 38:2065-2072.
20. Pankuch, G. A., C. Lichtenberger, M. R. Jacobs, and P. C. Appelbaum. 1996. Antipneumococcal activities of RP 59500 (quinupristin-dalfopristin), penicillin G, erythromycin, and sparfloxacin determined by MIC and rapid time-kill methodologies. Antimicrob. Agents Chemother. 40:1653-1656.
21. Spangler, S. K., M. R. Jacobs, and P. C. Appelbaum. 1992. Susceptibilities of penicillin-susceptible and -resistant strains of Streptococcus pneumoniae to RP 59500, vancomycin, erythromycin. PD 131628, sparfloxacin, temafloxacin, Win 57273, ofloxacin, and ciprofloxacin. Antimicrob. Agents Chemother. 36:856-859.
22. Spangler, S. K., M. R. Jacobs, and P. C. Appelbaum. 1996. Activities of RPR 106972 (a new oral streptogramin), cefditoren (a new oral cephalosporin), two new oxazolidinones (U-100592 and U-100766), and other oral and parenteral agents against 203 penicillin-susceptible and -resistant pneumococci. Antimicrob. Agents Chemother. 40:481-484.
23. Visalli, M. A., M. R. Jacobs, and P. C. Appelbaum. 1996. MIC and time-kill study of activities of DU-6859a, ciprofloxacin, levofloxacin, sparfloxacin, cefotaxime, imipenem, and vancomycin against nine penicillin-susceptible and -resistant pneumococci. Antimicrob. Agents Chemother. 40:362-366.